BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26134035)

  • 1. 2015 ACC/HRS/SCAI left atrial appendage occlusion device societal overview.
    Masoudi FA; Calkins H; Kavinsky CJ; Drozda JP; Gainsley P; Slotwiner DJ; Turi ZG
    Heart Rhythm; 2015 Oct; 12(10):e122-36. PubMed ID: 26134035
    [No Abstract]   [Full Text] [Related]  

  • 2. 2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview.
    Masoudi FA; Calkins H; Kavinsky CJ; Drozda JP; Gainsley P; Slotwiner DJ; Turi ZG
    J Am Coll Cardiol; 2015 Sep; 66(13):1497-513. PubMed ID: 26133570
    [No Abstract]   [Full Text] [Related]  

  • 3. Percutaneous left atrial appendage closure is not ready for routine clinical use.
    Mandrola J; Foy A; Naccarelli G
    Heart Rhythm; 2018 Feb; 15(2):298-301. PubMed ID: 29030233
    [No Abstract]   [Full Text] [Related]  

  • 4. 2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A professional societal overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.
    Masoudi FA; Calkins H; Kavinsky CJ; Slotwiner DJ; Turi ZG; Drozda JP; Gainsley P; ; ;
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):791-807. PubMed ID: 26256562
    [No Abstract]   [Full Text] [Related]  

  • 5. Closure of Left Atrial Appendage to Prevent Stroke: Devices and Status.
    Safavi-Naeini P; Rasekh A
    Tex Heart Inst J; 2018 Jun; 45(3):172-174. PubMed ID: 30072856
    [No Abstract]   [Full Text] [Related]  

  • 6. Left atrial appendage occlusion for the reduction of stroke and embolism in patients with atrial fibrillation.
    Gibson DN; Price MJ; Ahern TS; Teirstein PS
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):131-7. PubMed ID: 22193834
    [No Abstract]   [Full Text] [Related]  

  • 7. Left atrial appendage closure devices: A reasonable therapeutic alternative.
    Reddy VY
    Heart Rhythm; 2018 Feb; 15(2):302-305. PubMed ID: 29030234
    [No Abstract]   [Full Text] [Related]  

  • 8. SCAI/ACC/HRS institutional and operator requirements for left atrial appendage occlusion.
    Kavinsky CJ; Kusumoto FM; Bavry AA; Bailey SR; Ellenbogen KA; Hess PL; Lustgarten DL; Moussa ID; Spies C
    Heart Rhythm; 2016 May; 13(5):e241-e250. PubMed ID: 26686805
    [No Abstract]   [Full Text] [Related]  

  • 9. Left Atrial Appendage Occlusion With the LAmbre Device: Initial Experience.
    Cruz-González I; Freixa X; Fernández-Díaz JA; Moreno-Samos JC; Martín-Yuste V; Goicolea J
    Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):755-756. PubMed ID: 28522304
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term Outcomes Following Left Atrial Appendage Closure: Gaining Perspective on Non-pharmacological Stroke Prevention in Atrial Fibrillation.
    Asmarats L; Rodés-Cabau J
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):440-442. PubMed ID: 30670356
    [No Abstract]   [Full Text] [Related]  

  • 11. Dealing With the Left Atrial Appendage for Stroke Prevention: Devices and Decision-Making.
    Phillips KP; Paul V
    Heart Lung Circ; 2017 Sep; 26(9):918-925. PubMed ID: 28652029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Appendage Occlusion: A Narrative Review.
    Alsagheir A; Koziarz A; Belley-Côté EP; Whitlock RP
    J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1753-1765. PubMed ID: 30857852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCAI/ACC/HRS Institutional and Operator Requirements for Left Atrial Appendage Occlusion.
    Kavinsky CJ; Kusumoto FM; Bavry AA; Bailey SR; Ellenbogen KA; Hess PL; Lustgarten DL; Moussa ID; Spies C
    J Am Coll Cardiol; 2016 May; 67(19):2295-2305. PubMed ID: 26686261
    [No Abstract]   [Full Text] [Related]  

  • 14. Large pectinate muscle obstructing WATCHMAN™ left atrial appendage occlusion device placement.
    Patel NJ; Ellis CR
    J Interv Card Electrophysiol; 2016 Dec; 47(3):373-374. PubMed ID: 27435078
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical device regulatory reform: insights from the watchman left atrial appendage closure technology for stroke prophylaxis in atrial fibrillation.
    Cingolani E; Stevens S; Shehata M; Diamond GA; Kaul S
    Arch Intern Med; 2011 Oct; 171(18):1670-2. PubMed ID: 21746999
    [No Abstract]   [Full Text] [Related]  

  • 16. Where We Stand on Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.
    Safavi-Naeini P; Rasekh A
    Tex Heart Inst J; 2016 Aug; 43(4):320-3. PubMed ID: 27547142
    [No Abstract]   [Full Text] [Related]  

  • 17. [Percutaneous closure of left atrial appendage in non-valvular atrial fibrillation--international and Hungarian experiences].
    Fontos G; Andréka P; Temesvári A; Wéber D; Szatmári A
    Orv Hetil; 2010 May; 151(18):725-34. PubMed ID: 20409999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide levels variation after left atrial appendage occlusion.
    Cruz-Gonzalez I; Palazuelos Molinero J; Valenzuela M; Rada I; Perez-Rivera JA; Arribas Jimenez A; Gabella T; Prieto AB; Martín Polo J; Sánchez PL
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):E39-43. PubMed ID: 26033157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetech LAmbre: a new promising and novel device in the interventional stroke prevention.
    Schnupp S; Ajmi I; Brachmann J; Mahnkopf C
    Future Cardiol; 2019 Nov; 15(6):405-410. PubMed ID: 31710249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.